The LungPath study: Variation in the diagnostic and staging pathway for patients with lung cancer in England

Paul Cane*, Karen Linklater, George Santis, Henrik Møller, Mick Peake

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    The LungPath project investigated differences in lung cancer diagnostic practice by following the diagnostic pathways of 1507 patients from 19 representative English lung cancer centres. We found large variation in the proportion of patients receiving positron emission tomography-CT scan (range 13%-64%) and endobronchial ultrasound (range 2%-31%). There was also wide variation in the proportion of patients with good performance status who had their tumours histologically confirmed (range 61%-100%). The variation is discussed with reference to current national guidelines and implications for patient care.

    Original languageEnglish
    Pages (from-to)291-293
    Number of pages3
    JournalThorax
    Volume71
    Issue number3
    DOIs
    Publication statusPublished - Mar 2016

    Fingerprint

    Dive into the research topics of 'The LungPath study: Variation in the diagnostic and staging pathway for patients with lung cancer in England'. Together they form a unique fingerprint.

    Cite this